Emerging Role of Circular RNAs in the Pathogenesis of Retinoblastoma

Weizhen Wu1, Youjing Zhang1, Ming Yang1

  • 1Department of Ophthalmology, Beijing Friendship Hospital, Capital Medical University, Beijing, China.

Ophthalmic Research
|December 18, 2023
PubMed

Insights

Circular RNAs (circRNAs) are increasingly implicated in retinoblastoma (Rb) development. This review details how specific circRNAs can either promote or suppress Rb progression, offering insights into potential diagnostic and therapeutic strategies.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Retinoblastoma (Rb) is a common and aggressive childhood cancer originating in the eye.
  • Understanding Rb's molecular mechanisms is crucial for developing effective treatments and biomarkers.
  • Circular RNAs (circRNAs) have emerged as significant players in cancer development.

Purpose of the Study:

  • To review the functional roles of circRNAs in retinoblastoma (Rb) pathogenesis.
  • To explore the potential clinical applications of circRNAs in Rb diagnosis and prognosis.
  • To provide a comprehensive understanding of circRNAs in Rb pathophysiology.

Main Methods:

  • Literature review of studies investigating circRNAs in retinoblastoma.
  • Analysis of identified circRNAs that promote or suppress Rb progression.
  • Summary of current knowledge on circRNA involvement in Rb cellular processes.

Main Results:

  • Several circRNAs (e.g., circ_0000034, circFAM158A) promote Rb progression and metastasis.
  • Other circRNAs (e.g., circ_0001649, circMKLN1) exhibit tumor-suppressive roles in Rb.
  • CircRNAs regulate key cancer processes including proliferation, apoptosis, migration, and invasion in Rb.

Conclusions:

  • CircRNAs play diverse and critical roles in the development and progression of retinoblastoma.
  • CircRNAs hold significant potential as diagnostic markers and therapeutic targets for Rb.
  • Further research into circRNA functions can advance Rb treatment strategies.

Related Concept Videos

The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.1K
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
5.1K
Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.1K
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
35.4K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.8K
lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.6K